<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01916915</url>
  </required_header>
  <id_info>
    <org_study_id>09/06</org_study_id>
    <nct_id>NCT01916915</nct_id>
  </id_info>
  <brief_title>Usage of Tramadol With Levobupivacaine for Pain Treatment After Cesarean Section</brief_title>
  <official_title>The Effect of Addition of Tramadol to Levobupivacaine in Continuous Wound Infusion for Postoperative Pain Treatment in Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ufuk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ufuk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients experience considerable amount of pain after cesarean section. The aim of this study
      is to investigate the effect of tramadol (an opioid pain killer) added to levobupivacaine (a
      local anesthetic) in continuous wound infusion (which is done by placing a catheter in the
      incision) after cesarean sections.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lowering of pain as measured by visual analogue scores</measure>
    <time_frame>forty eight hours after the operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>total additional analgesic consumption</measure>
    <time_frame>forty eight hours after the operation</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Tramadol 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg/kg tramadol + 0.25% levobupivacaine 4 ml/h infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tramadol 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2mg/kg tramadol + 0.25% levobupivacaine 4 ml/h infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.25% levobupivacaine 4ml/h infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol infusion via wound catheter</intervention_name>
    <arm_group_label>Tramadol 1</arm_group_label>
    <arm_group_label>Tramadol 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <arm_group_label>Tramadol 1</arm_group_label>
    <arm_group_label>Tramadol 2</arm_group_label>
    <arm_group_label>Levobupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planned cesarean section

          -  American Society of Anesthesiologists Class I-II

        Exclusion Criteria:

          -  Patients refusing to enroll in the study

          -  Serious coagulopathy

          -  Serious systemic disease

          -  Story of allergy to drugs being used in the study

          -  Morbid obesity (Body mass index &gt; 30)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Perihan Ekmekçi, Associate Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ufuk University Dr Rıdvan Ege Hospital Department of Anesthesiology and Reanimation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ufuk University Dr Rıdvan Ege Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06520</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2013</study_first_submitted>
  <study_first_submitted_qc>August 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2013</study_first_posted>
  <last_update_submitted>June 28, 2016</last_update_submitted>
  <last_update_submitted_qc>June 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ufuk University</investigator_affiliation>
    <investigator_full_name>Perihan Ekmekçi</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

